Home › Alere Receives FDA Clearance for Respiratory Syncytial Virus MDx

Alere Receives FDA Clearance for Respiratory Syncytial Virus MDx

Aug 19, 2016

NEW YORK (GenomeWeb) – Alere announced today that it has received 510(k) clearance from the US Food and Drug Administration for a point-of-care isothermal nucleic acid amplification test that detects respiratory syncytial virus infection in children and adults from nasopharyngeal swab samples in 13 minutes or less.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oct
02
Featured Webinar

Utilization of Multiple Molecular Testing Methodologies to Aid in Lung Cancer Patient Management

In the last few years several molecular testing methodologies — such as immunohistochemistry, PCR, and sequencing — have been approved by the US Food and Drug Administration to aid in the management of patients with lung cancer.  

Oct
10
Featured Webinar

Personalization of Oncology Pathways: Clinical Quality Initiatives Amid a Complex Molecular Landscape

This webinar will provide a first-hand look at how the Dana-Farber Cancer Center is adapting its oncology care strategy in light of the rapidly evolving molecular landscape.

Nov
05
Featured Webinar

Overcoming Challenges in Solid Tumor Testing with Advanced AI

Sponsored by
Sophia Genetics

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.

What's Popular?

In Molecular Diagnostics

  1. Premaitha Licenses NIPT Tech From Illumina Under Settlement

  2. Cepheid Fingerstick HCV Test Receives CE-IVD Clearance

  3. Qiagen, NeuMoDx Ink Partnership, Merger Agreement

  4. Noridian Issues Draft LCD for GenomeDx Prostate Biopsy Genomic Classifier

  5. India's MolBio Brings Tuberculosis MDx to Point of Care With Help From FIND

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.